Animal growth and development is dependent on reiterative use of key signaling pathways such as Hedgehog (Hh) pathway. It is widely believed that Cubitus-interruptus (Ci) mediates all functions of Hh pathway. Here we report that CG32062, the Drosophila homologue of Ataxin-2 Binding Protein 1 (dA2BP1), functions as a cofactor of Ci to specify intervein region between L3 and L4 veins of the adult wing. Specifically, Ci-mediated transactivation of knot/collier (kn) in this region of the developing wing imaginal disc is dependent on dA2BP1 function. Protein interaction studies and chromatin-immunoprecipiation experiments suggest that Ci helps dA2BP1 to bind kn promoter, which in turn may help Ci to activate kn expression. These results suggest a mechanism by which Ci may activate targets such as kn, which do not have classical Ci/Gli-binding sites.
Introduction
Growth and patterning during fly wing development are mediated by signaling from its anterior-posterior (A/P) and dorsalventral (D/V) organizers. The A/P compartmentalization is controlled by the expression of engrailed (en; Lawrence and Morata, 1976) , a selector gene that specifies posterior identity (Kornberg et al., 1985) . En activates hedgehog (Hh), which is a short-range morphogen that diffuses to the anterior compartment, and activates Smoothened (Smo) by releasing it from Patched (Ptc). In the presumptive A/P boundary, Smo activates Cubitus-interruptus (Ci) by stabilizing its full-length isoform, which in turn activates targets of Hh, particularly Decapentaplegic (Dpp) and Knot/Collier (Kn) . Ci also activates Ptc and thus, a higher concentration of Ptc receptor is maintained at the AP boundary (reviewed by Aza-Blanc et al., 1997) .
A combination of repressor activity of 75 kDa form and activator activity of 155-kDa form of Ci regulate the expression of different sets of target genes (Methot and Basler, 2001; Wang and Holmgren, 1999) . This, however, is thought to be mediated by Ci binding to similar binding sites (Muller and Basler, 2000) . Targets of Ci such as ptc, dpp, wg possess well characterized binding sites on their promoters (Alexandre et al., 1996; Hidalgo and Ingham, 1990; Muller and Basler, 2000; Von Ohlen et al., 1997) . However, classical Gli/Ci-binding sites are not present on kn promoter (Hersh and Carroll, 2005) . This suggests that the mechanism of Ci-mediated activation of kn may be different from the mechanism activating ptc or dpp expression.
Previously, we reported the identification of CG32062 in an enhancer-trap screen to identify genes that show differential expression between wing and haltere discs (Bajpai et al., 2004) . Here we report functional characterization of CG32062. Sequence analyses suggest that protein encoded by CG32062 (hereafter referred to as dA2BP1) is the closest homologue of human Ataxin-2 Binding Protein 1 (A2BP1). In mammals including human, expansion of polyglutamine repeats in Ataxin-2 causes Spinocerebellar ataxia type 2 (SCA2), a neuro-degenerative disease. The Ataxin-2 activity is modulated by A2BP1, which binds to the C-terminus of the former (Shibata et al., 2000) .
dA2BP1 shows a dynamic expression pattern; both spatially and temporally. The protein is predominantly nuclear with traces of the protein in the cytoplasm. Removal of dA2BP1 function causes formation of ectopic veins and loss of intervein region, a phenotype similar to those caused by loss-of-function alleles of kn. Epistasis experiments suggested dA2BP1 interacts with Ci to activate the expression of kn. Protein interaction studies and chromatin-immunoprecipiation experiments suggest that Ci helps dA2BP1 to bind kn promoter, which in turn may facilitate Ci to activate kn expression. Results presented here suggest that dA2BP1 may facilitate activation of those targets of Ci such as kn, which do not have classical Ci/Glibinding sites. Developmental Biology 341 (2010) [389] [390] [391] [392] [393] [394] [395] [396] [397] [398] [399] Materials and Methods
Genetics
Recombinant chromosomes and combinations of GAL4 drivers and UAS lines, generation of different mutations and markers, molecular cloning and associated nucleic acid and protein techniques (expression, purification, immunoprecipitation etc) were as per the standard genetic and molecular procedures. The LD15974 (Berkeley Drosophila Genome Project), the cDNA representing full-length CG32062-RE isoform, was used to express dA2BP1 in E. coli (bacterially expressed protein was used to raise polyclonal antibodies against dA2BP1) and to generate transgenic UAS-dA2BP1. Cloning strategies, sequence of PCR primers, details of GST-pull down assay and immunoprecipitation experiments are described in the supplement text.
Several flystocks were obtained from various sources: GAL4 strains used are Actin5c N CD2 N GAL4 (Pignoni and Zipursky, 1997) , C96-GAL4 (Gustafson and Boulianne, 1996) , ap-GAL4 (Calleja et al., 1996) , EN403-GAL4 (Bajpai et al., 2004) , MS1096-GAL4 (Capdevila et al., 1994) , omb-GAL4 (personal communication to Flybase, Calleja, 1996.10.16) , ptc-GAL4 (Brand and Perrimon, 1993) and vg-GAL4 (Simmonds et al., 1995) . Other fly-strains used: UAS-Ci (Aza-Blanc et al., 1997) , UAS-Ci-HA (Wang and Holmgren, 1999) , dpp BS3.0 -lacz (Blackman et al., 1991) , UAS-Dsh (Neumann and Cohen, 1996) , EN403-lacZ (Bajpai et al., 2004) , UAS-mCD8::GFP (Lee and Luo, 1999) , hs-FLP (Xu and Rubin, 1993) , UAS-Kn (Mohler et al., 2000) , kn-lacZ (Hersh and Carroll, 2005) and UAS-Notch intra (Fortini et al., 1993) . The P-insertion y 1 w 67c23 ; P{EPgy2}EY01049/TM3, Sb 1 Ser 1 (Bloomington Stock # 15489) in dA2BP1 is described in Flybase.
Histology
RNA in situ and immunochemical staining on embryos and imaginal discs were performed as described earlier Patel et al. (1989) and Tautz and Pfeifle (1989) . LD15974 and RE20611 were used as templates to generate DIG-labelled probes for RNA in situ for dA2BP1 and dpp, respectively. Antibodies used were, anti-dA2BP1 (1:1), monoclonal anti-Cut (1:10; Blochlinger et al., 1993) , anti-β-Galactosidase and anti-GFP (Molecular Probes), anti-HA (1:1000; Roche), anti-DSRF (1:100; Montagne et al., 1996) , anti-dpERK1/2 (1:50; Sigma, USA), anti-Ci (raised in rat; 1:5; Motzny and Holmgren, 1995) , anti-Caspase 3 (1:300; Cell Signaling), monoclonal anti-Wg (1:500; Brook and Cohen, 1996) , anti-Delta (1:100; Qi et al., 1999) ) anti-Ubx (1:30; White and Wilcox, 1984) ; anti-Ptc (1:50; Capdevila et al., 1994) , anti-Hh (1:1000; Tabata and Kornberg, 1994), anti-En (1; 200; Patel et al., 1989) . Antibodies against Wg and Dl were obtained from Developmental Studies Hybridoma Bank (DSHB), Iowa, USA. All secondary antibodies conjugated to Alkaline Phosphatase or Horse Radish Peroxidase were purchased from Jackson Immuno Research Laboratories, USA and those conjugated to fluorophores were purchased from Molecular Probes, USA. Protein A Agarose (Amersham) or Protein G Agarose (Upstate) were used for immunoprecipitation experiments.
Chromatin immunoprecipitation (ChIP) experiments
The ChIP protocol used is modified from Papp and Muller (2006) and Sanchez-Elsner et al. (2006) . Chromatin of 500 bp-2 kb was isolated from wing discs of larvae of desired genotype and subjected ChIP using goat anti-Ci (Santacruz, USA) or anti-dA2BP1 antibodies. The immunoprecipitated DNA was subjected to PCR amplification with primers designed to amplify those regions of kn and dpp genes, which harbour Ci-binding motifs (Hersh and Carroll, 2005; Muller and Basler, 2000) . Primers against a region of kn with no known binding sites for Ci, which is more than 20 kb away from the region with Ci binding site, was also included in all experiments. ChIP experiments for a region of 3rd exon of Rpl32 served as negative control and the same was used to normalize the differences between mock and test of a given experiment. Details of the procedure and sequences of primers used are given in the Supplement Text.
Electromobility shift assays
The ability of purified dA2BP1 (bacterially expressed) to bind kn promoter was examined using electromobility shift assays as described earlier (Pallavi et al., 2006) . The protein + DNA mix was electrophoretically resolved on 5% polyacrylamide gels. Probes used:
(1) PCR amplified kn and dpp cis-regulatory regions using the same primers as used for ChIP. (2) a 60-mer oligo comprising Ci-binding sites on kn and its mutated version. Sequences of the two oligomers used are shown in the Supplement Table 1 .
Results

Loss of dA2BP1 causes loss of intervein tissue in the adult wing
The dA2BP1 gene in Drosophila, is a complex locus spanning more than 80 kb of the genomic region located at 67E1-2 polytene position (Bajpai et al., 2004) . Based on the analyses of ESTs for this gene, dA2BP1 is predicted to have 17 exons coding for 5 isoforms (http:// www.flybase.org). In addition to a predicted RNA-recognition motif, all isoforms of dA2BP1 have 2 long poly-Q domains (Suppl. Fig. 1 ).
To address the role of this gene in the growth and patterning, we started by examining the expression pattern of this gene in developing tissues. First, we raised antibodies against a variant of dA2BP1 protein containing all the predicted functional domains of dA2BP1 (Suppl. Fig. 1 ). We examined the expression of dA2BP1 during embryonic development and in the larval imaginal discs. In embryos, expression of dA2BP1 was primarily in the central and peripheral nervous systems (Suppl. Fig. 2A, B ). Expression was also noted in embryonic pericaridial cells (Suppl. Fig. 2B ).
In the 3rd instar larva, expression of dA2BP1 was observed in all imaginal discs. In wing imaginal discs, expression was seen in the pouch region as well as the notum. Within the pouch region, cells away from the dorsal-ventral (D/V) compartment boundary showed relatively higher levels of expression as compared to the cells at the D/V boundary ( Fig. 1A ). This is similar to the RNA in situ pattern reported for this gene (Bajpai et al., 2004) . The expression of dA2BP1 in the notum appeared to be in myoblasts; this was confirmed by its co-localization with the transcription factor Cut, which marks these cells ( Fig. 1A ). In addition to the pouch and notum regions, dA2BP1 expression was also observed in peripodial cells of the wing disc (data not shown).
As mentioned earlier, dA2BP1 was identified in an enhancer trap screen. The enhancer trap line EN403-lacZ is inserted within the 49 kb long intron of the dA2BP1 gene (Bajpai et al., 2004) . To determine if the anti-dA2BP1 staining pattern in the wing discs is in the same cells that express EN403-lacZ, we carried out a double staining with anti-dA2BP1 and anti-βgal antibodies on EN403-lacZ wing discs. dA2BP1 and β-gal were found colocalized in the wing pouch ( Fig. 1B ), suggesting that the anti-A2BP1 antibodies recognize the gene product trapped by EN403-lacZ.
In addition to the wing disc, expression of dA2BP1 was also detected in other imaginal discs. In the leg and antennal discs, staining was observed in the central region (data not shown); in the eye imaginal discs, the protein was detected predominantly in cells posterior to the morphogenetic furrow (Suppl. Fig. 2E ). In all cases, the protein appeared to be nuclear ( Fig. 1A ; Suppl. Fig. 2) .
We had previously shown that expression of dA2BP1 is dependent on Notch signaling at the D/V boundary (Bajpai et al., 2004) . However, the functional role of dA2BP1 in wing patterning was not explored. To address this question, we attempted to generate loss-of-function alleles of dA2BP1 by trying to mobilize the P-element in EN403-lacZ and P{EPgy2}EY01049). Several attempts to generate loss-of-function alleles of dA2BP1 failed (see supplement text for details) and, in the absence of any deficiency stocks for this region, we employed RNAimediated gene knock-down approach to examine the effect of downregulation of dA2BP1.
We designed and generated dA2BP1 RNAi transgenes (UAS-dA2BP1 RNAi ) that would generate dsRNA against the RNA binding domain. As this domain is common to all isoforms of dA2BP1, we predicted that the RNAi transgene would knock-down expression of all isoforms. In addition, this was the only domain that predicted not to generate any possible off-target effects. To test the efficacy of these RNAi lines, we crossed them to different GAL4 drivers such as omband ptc-GAL4, which express in the pouch region of the wing imaginal disc and carried out immunohistochemistry using anti-dA2BP1 antibodies. Expression of UAS-dA2BP1 RNAi resulted in a considerable decrease in the expression of dA2BP1 in omb-and ptc-GAL4 domains (Fig. 1C ; Suppl. Fig. 3A ). RNAi-mediated knock-down of dA2BP1 using ubiquitous GAL4 drivers such as tubulin-GAL4, hs-GAL4 resulted in early larval lethal, suggesting vital functions for dA2BP1 during early development.
To examine the effect of knock-down of dA2BP1 on wing morphology, we first expressed dA2BP1 RNAi using EN403-GAL4 whose expression reflects the endogenous expression pattern of the gene (Bajpai et al., 2004) . Interestingly, all the adult flies that emerged had only one specific phenotype viz., loss of intervein region and ectopic cross veins between L3 and L4 of the adult wing blade ( Fig. 1E ; penetrance -85%; n N 75). As mentioned earlier, D/V boundary cells express lower levels of dA2BP1 as compared to cells away from the boundary. Down-regulation of dA2BP1 (using vg-GAL4 and C96-GAL4 drivers) in these cells did not result in any wing phenotype and the progeny were fully viable (n N 75).
Next, we examined the effect of knock-down of dA2BP1 using different GAL4 drivers, which are expressed in different regions of the wing disc. omb-GAL4 expresses in the central region of the wing pouch; ap-GAL4 and MS1096-GAL4 express in the dorsal compartment of the disc, and ptc-GAL4 is expressed only in the anterior cells immediately adjacent to the A/P boundary (hereafter referred to as AB cells). When crossed to these GAL4 drivers, UAS-dA2BP1 RNAi caused loss of intervein region and fusion of veins L3 and L4. In some cases, the amount of vein material appeared to be more suggesting the formation of ectopic vein tissue ( Fig. 1F , G; Suppl. Fig. 3C , D; penetrance 85-100%; n N 75 for all crosses).
Clonal induction of dA2BP1 RNAi expression also caused ectopic veins in the wing blade (n = 85), while majority (n = 60) of flies displayed ectopic vein between L3 and L4 (Suppl. Fig. 3E -G). When Fig. 1 . dA2BP1 is required for the specification of the intervein region in the wing. (A) Wild type wing discs stained with anti-dA2BP1 (red) and anti-Cut (green). dA2BP1 is expressed in the wing pouch (asterisk) and myoblast cells in the notum (arrow) as determined by the expression of Cut. (B) Expression of dA2BP1 in the wing pouch is identical to the enhancer trap line EN403-LacZ (green). The expression is relatively higher in non-D/V cells than in D/V cells. (C) omb-GAL4/UAS-dA2BP1 RNAi ; UAS-GFP/+ wing discs stained with anti-dA2BP1 (red) and anti-GFP (green) antibodies (B). Note loss of dA2BP1 in omb-GAL4 domains (asterisk). The large nuclei that are stained in this domain are of peripodial cells and not in the disc proper cells. (D) Wildtype wing blade. Five distinct veins (numbered) with two cross veins between veins 3 and 4 and between 4 and 5 (arrowheads) are marked. (E) EN403-GAL4 N dA2BP1 RNAi wing blade. Multiple crossveins develop between veins 3 and 4. Also note loss of intervein in that region. (F-G) Expression of dA2BP1 RNAi using omb-GAL4 (F) and MS1096-GAL4 (G) leads to loss of the intervein region between veins 3 and 4 and formation of excess vein tissue (arrows in F and G).
UAS-dA2BP1
RNAi was crossed to MS1096-GAL4 in the presence of one copy of P-insertion in dA2BP1 (P{EPgy2}EY01049), we observed enhanced L3/L4 vein phenotype: fusion of L3 and L4 accompanied by thickening of the fused vein was observed. In addition, large patches of ectopic veins in regions beyond L5 were observed (Suppl. Fig. 3H ). These results suggest that while dA2BP1 may have a role in the specification of the entire wing blade, L3-L4 vein/intervein specification is more sensitive to small perturbations in the levels of dA2BP1.
dA2BP1 regulates Knot/Collier expression
To test if this phenotype was caused by cell death of intervein specifying cells, we stained RNAi expressing wing discs with anti-Caspase3, Acridine-orange and DAPI. However, no indication of cell death was observed (data not shown). Furthermore, co-expression of UAS-P35 or UAS-CycE did not rescue UAS-dA2BP1 RNAi -induced wing phenotype suggesting that knock-down of dA2BP1 interferes with the specification of intervein region. We, therefore, examined the effect of dA2BP1 RNAi on the EGFR/Ras and Notch signaling pathways which are known to specify vein and intervein regions (reviewed in de Celis, 2003) . Components of EGFR/Ras pathway such as dpERK1/2 (transducer of the EGFR/Ras signal) and Argos (negative feed-back regulator) are expressed in the presumptive vein regions (Suppl. Fig. 4A , C). Dl (the ligand of Notch) is also expressed in the presumptive veins (Suppl. Fig. 4E ), but activates Notch pathway in adjacent intervein regions. Upon expression of dA2BP1 dsRNA, we observed fusion of the two stripes expressing dpERK1 and Argos, which represent presumptive L3 and L4 veins (Suppl. Fig. 4B , D) and, loss of Dl staining in those cells (Suppl. Fig. 4F ). Fusion of dpERK1 and Argos stripes and loss of Dl reflect the observed fusion of L3 and L4 veins and loss of the intervein region in adult wings.
In addition to EGFR/Ras and Notch pathways, DSRF (a target of Hh pathway; Nussbaumer et al., 2000) is expressed (Suppl. Fig. 4G ) and required in all intervein regions. Consistent with L3-L4 intervein region being very sensitive to knock-down of dA2BP1, we observed loss of DSRF only in L3-L4 intervein region, although its expression overlaps with that of dA2BP1 in 4 stripes, representing four major intervein regions (Suppl. Fig. 4H ).
The transcription factor Kn functions by activating DSRF and repressing EGFR/Ras signaling (Vervoort et al., 1999; Crozatier et al., 2002; Mohler et al., 2000 ; for a review see de Celis, 2003) . Loss of kn results in the loss of L3-L4 intervein region, a phenotype identical to the one observed by knocking-down dA2BP1 (Crozatier et al., 2002; Mohler et al., 2000) . Conversely, over-expression of Kn results in loss of vein tissue (Mohler et al., 2000) . Given the strong similarity in the loss-of-function phenotypes of kn and dA2BP1, we examined the possibility of an interaction between these two genes.
When Kn was over-expressed in a background compromised for dA2BP1 (omb-GAL4 driven expression of both UAS-Kn and UAS-dA2BP1 RNAi transgenes), the loss of vein tissue caused by Kn overexpression was dominant over loss of intervein tissue due to knockdown of dA2BP1 (data not shown).
Rescue of UAS-dA2BP1 RNAi -induced wing phenotype by the coexpression of Kn indicated that dA2BP1 might function upstream of kn. We examined the effect of knock-down of dA2BP1 on kn expression. We examined the effect of knock-down of dA2BP1 on kn expression by both RNA in situ and by monitoring the expression of its reporter gene kn-lacZ. Expression of UAS-dA2BP1 RNAi in the wing pouch lead to a significant reduction in the kn levels ( Fig. 2B, F) . Conversely, over-expression of dA2BP1 resulted in increased levels of kn expression ( Fig. 2G ).
In the absence of a null allele for dA2BP1, we examined the specificity and cell autonomy of RNAi-mediated phenotypes as follows: (1) dA2BP1 levels were reduced using MS1096-GAL4 driver, which expresses predominantly, but not exclusively, in the dorsal compartment of the wing pouch. We observed a correspondingly enhanced reduction ( Fig. 2F ) or increase (Fig. 2G ) in kn expression in the dorsal compartment when dA2BP1 levels were reduced or increased, respectively. kn expression in the ventral compartment remained relatively unaffected. (2) dA2BP1 RNAi transgene was expressed in a background of high levels of Dicer2 to ensure near complete knock-down of dA2BP1. We observed severe reduction in the levels of kn ( Fig. 2H ; effect was visible even in the ventral compartment) suggesting a dosage-dependent effect. We, however, could not observe corresponding wing phenotypes as these animals died at early pupal stages. (3) Next, we carried out simultaneous expression of both, UAS-dA2BP1 and UAS-dA2BP1 RNAi transgenes. Similar to the overexpression of UAS-dA2BP1 alone, combined expression of UAS-dA2BP1 and UAS-dA2BP1 RNAi transgenes lead to larval lethality. However, in the wing disc level, we observed a rescue of kn expression levels suggesting that dA2BP1 indeed regulates kn expression (Fig. 2I) .
The Vienna Drosophila RNAi collection has listed two RNAi transgenes for dA2BP1: ID 34046 and ID 34047. Both are predicted to have as many as 500 off targets. As expected, crossing these two lines with MS1096-GAL4 driver resulted in pupal lethality. However, despite the presence of a large number of off targets, we observed a reduction in kn expression in the wing disc (data not shown).
dA2BP1 functions as a potential cofactor of Cubitus-interruptus in regulating kn expression
Next, we examined the effect of modulating dA2BP1 levels on the expression of genes upstream of kn such as Ci, Ptc, Hh and En. We did not observe any significant change in the expression of these genes ( Fig 3A-D; Suppl. Fig. 5 ). This suggests that dA2BP1 may function downstream of or in parallel to Ci which is known to regulate kn expression (Hersh and Carroll, 2005) .
As mentioned above, when over-expressed in the entire dorsal compartment, dA2BP1 causes an increase in kn expression levels only in AB cells. These cells are known to express the stabilized 155 kDa form of Ci. In contrast, over-expression of Ci using MS1096-GAL4 driver causes ectopic expression of kn in the entire dorsal compartment of the wing pouch (Fig. 3E ). This effect of Ci over-expression was suppressed, albeit partially, when UAS-Ci was co-expressed with UAS-dA2BP1 RNAi (Fig. 3F) . As a control, we also examined the expression of dpp-lacZ in wing discs over expressing Ci. Similar to kn, over expression of Ci lead to ectopic expression of dpp in the entire dorsal compartment (Fig. 3G ). But, unlike kn, the expression of dpp was unaffected by dA2BP1 RNAi (Fig. 3H) . These results suggest specific interactions between dA2BP1and Ci to regulate kn expression in the wing disc. In these and subsequent sets of experiments, UAS-GFP was used as a control in combination with other UAS lines (UAS-dA2BP1 RNAi , UAS-dA2BP1, UAS-Ci etc) to rule out the possibility of any dilution effect of the GAL4.
dA2BP1 interacts with Ci through its C-terminal domain
Next, we examined if dA2BP1 physically interacts with Ci to regulate kn expression. Immunoprecipitation of dA2BP1 from nuclear extract of wildtype third instar larval wing discs using anti-dA2BP1 polyclonal antibodies resulted in co-precipitation of full-length (155 kDa) Ci (Fig. 4A ). As the anti-Ci antibodies used can detect only 155 kDa protein, this experiment did not confirm if dA2BP1 can also bind the 75 kDa form of Ci protein.
Several attempts to do the reverse experiment using anti-Ci antibodies to immunoprecipitate dA2BP1 failed. This was probably due to the poor efficacy of the antibodies used in these experiments. We therefore, used a transgene that expresses full-length Ci tagged with HA (Ci-HA; Wang and Holmgren, 1999) . Ci-HA was expressed in the wing pouch using MS1096-GAL4 driver. Nuclear extract of third instar larval wing discs were subjected to immunoprecipitation using anti-HA monoclonal antibodies or anti-dA2BP1 polyclonal antibodies. Immunoprecipitation of Ci-HA using anti-HA antibodies was confirmed by Western blot using anti-Ci antibodies (Fig. 4B ). Precipitation using anti-HA antibodies also lead to co-precipitation of dA2BP1 (Fig. 4C ). Immunoprecipitation of dA2BP1 from Ci-dA2BP1 expressing wing discs using anti-dA2BP1 polyclonal antibodies also resulted in the co-precipitation of Ci-HA (Fig. 4D) .
To identify the domain in dA2BP1 which is essential for its interaction with Ci, we cloned and expressed GST tagged truncated proteins corresponding to amino acids 1-517 of the N-terminus; residues 395-476 of the RNA-binding motif and, amino acids 478-865 of the C-terminal domain (Fig. 4E, F) . The purified GST-tagged fusion proteins were challenged with wing disc lysate and immunoprecipitated using anti-GST antibodies. Western blot analyses with anti-Ci antibodies revealed that only the construct with amino acids 478-865 binds to Ci (Fig. 4G ). This suggests that a region between amino acids 518-865 of dA2BP1 is critical for its binding to Ci.
dA2BP1 binds directly to the kn promoter to regulate its expression
The wing-enhancer element of kn is known to harbor, at least, three Ci-binding sites, although only one site (at Chr2R: 10699592-10699600) is shown to be functional (Hersh and Carroll, 2005) . To understand the mechanism by which these two proteins interact to regulate kn expression, we asked if dA2BP1 binds directly to the kn promoter. We first carried out electromobility shift assays to determine if dA2BP1 could independently bind to DNA. Varying amounts of purified dA2BP1 protein was incubated with radio-labeled kn or dpp probes, which have known Ci binding sites (see Suppl. text). A clear shift in mobility was observed for the kn probe, but not for dpp probe (Fig. 5A ). This binding could be competed out by the addition of varying amounts of cold unlabelled probe (Fig.5B ). We also compared the binding of dA2BP1 to kn probes that had intact Ci binding site and to those which had mutated Ci binding site. In both cases, we were able to detect shifts in mobility (Fig. 5C) indicating that, in-vitro, dA2BP1 may bind to regions other than Ci-binding region of the kn promoter. dA2BP1 did not bind to dpp sequences, suggesting sequence specificity in its binding properties. DNA-binding properties have been reported earlier for at least one RNA-binding protein; TIAR (Suswam et al., 2005) . Furthermore, they have observed that the RNA recognition motifs of TIAR themselves show DNA binding activity. However, the predicted RNA-binding domain of dA2BP1 (395-476aa) alone failed to bind kn DNA in our electromobility shift assays (data not shown). Understanding of the mechanism by which dA2BP1 binds kn promoter needs further investigation involving precise molecular experiments. To test if dA2BP1 binds kn promoter in-vivo, we carried out Chromatin immunoprecipitation experiments (ChIP) on chromatin isolated from wildtype wing discs using antibodies against dA2BP1. Subsequently, PCR was carried out on the precipitated DNA using primers designed to a region (kn + ; Fig. 6 ) within the regulatory region used in kn-lacZ (Hersh and Carroll, 2005) . This region includes the only known functional Ci-binding site (at Chr2R: 10699592-10699600). As described above, the expression of this reporter is under the regulation by dA2BP1 (Fig. 2B ). In addition to kn + sequences, a region of dpp, known to harbor functional Ci-binding sites was also tested for the binding of dA2BP1. A region in the 3rd exon of Rpl32 was used for normalizing ChIP data and a region in the 3′ end of kn, which doesn't not have any known or predicted Ci binding sites (kn -) was used as negative control (Fig. 6 ). ChIP carried out using dA2BP1antibodies showed that the protein binds to kn + sequences (Fig. 6A; arrow) . We did not observe binding of dA2BP1 to the 3′ region of kn nor to the dpp promoter.
As dA2BP1 has characteristic RNA recognition motif, it is possible that dA2BP1 binds to kn RNA at the site of transcription itself and enhances kn transcription by processing kn RNA co-transcriptionally. Such mode of gene regulation has been reported for few RNA binding proteins (Swinburne et al., 2006) . This is unlikely for dA2BP1 as its effect on the regulation of kn expression was observed using a kn-lacZ reporter construct, which carries just a short enhancer fragment from a region that is nearly 5 kb away from the transcription initiation site of kn (Hersh and Carroll, 2005) . In addition, overexpression of Kn did not affect kn-lacZ expression (data not shown), supporting previous reports that ruled out auto-regulation of kn (Crozatier et al., 2002) .
dA2BP1 can suppress the dominant negative effect of Ci 75
ChIP was also carried out using anti-Ci antibodies, which as expected, showed specific binding to kn + and dpp sequences (Fig. 6B,  arrows) . However, knock-down of dA2BP1 did not affect the ability of Ci to bind to the promoter of kn (Fig. 6C) . To investigate precise interactions between dA2BP1 and Ci, we expressed various deletion constructs of Ci and examined the ability of dA2BP1 to suppress the effects of over-expressed Ci on kn expression.
We examined the ability of UAS-dA2BP1 RNAi or UAS-dA2BP1 to modulate phenotypes caused by the over-expression of constitutively active or dominant negative forms of Ci, respectively. This is based on the assumption that they would modulate only if the two proteins interact. Ci protein has several distinct functional domains such as Nterminal repressor domain, DNA-binding Zn finger domain, proteolytic site, phosphorylation (by PKA) site and C-terminal dCBP-binding activator domain (Suppl. Fig. 6 ). Including wildtype Ci, we expressed as many as 10 different Ci constructs (Suppl. Fig. 6 ; Suppl. Table 3 ) and examined their effect on kn expression. All these constructs have been previously reported and few of them act as constitutively active Ci, while others manifest as dominant negative to endogenous Ci (Suppl. Table 3 ). Transgenes Ci ΔC1 and Ci ΔNC1 , which have intact Zn-finger domain and dCBP-binding domain, activated kn expression in the entire dorsal compartment when expressed using MS1096-GAL4 driver (Suppl. Fig. 7) . Ci GA1 and Ci GA2 , which have intact Zn finger domain fused to GAL4 activator domain (in the absence of dCBPbinding domain), also activated kn expression, although only in the posterior compartment (Fig. 7B ). Since ectopic activation of kn expression by wildtype Ci is dependent on dA2BP1 function (Fig. 5F) , we examined if the activity of this constitutively active Ci form is subject to modulation by dA2BP1 function. RNAi-mediated down-regulation of dA2BP1 reduced ectopic activation of kn caused by Ci GA2 suggesting that the two proteins can still interact with each other and this interaction is essential for the ability of Ci to activate kn expression ( Fig. 7B'; Suppl. Fig. 7 ; Suppl. Table 3) .
Ci constructs, with dCBP-binding domain deleted and with various additional deletions, did not cause ectopic activation of kn expression when expressed using MS1096-GAL4 driver. They, in fact, suppressed endogenous levels of kn expression in AB cells suggesting dominant Ptc (C-D). Knock-down of dA2BP1 has no effect on the expression of either of the two proteins and other upstream regulators of Ci viz., En and Hh (see suppl . Fig). (E-H) MS1096-GAL4/+; UAS-Ci/kn-lacZ (E), MS1096-GAL4/UAS-dA2BP1 RNAi ; UAS-Ci/kn-lacZ (F), MS1096-GAL4/+; UAS-Ci/dpp-lacZ (G) and MS1096-GAL4/ UAS-dA2BP1 RNAi ; UAS-Ci/dpp-lacZ (H) wing discs stained with anti-β-galactosidase antibodies. MS1096-GAL4 driven ectopic activation of Ci causes ectopic expression of both kn-lacZ and dpp-lacZ in the entire dorsal compartment. However, when Ci is expressed in animals with compromised dA2BP1 function, the ectopic expression of kn-LacZ is considerably suppressed (F) with little or no effect on the expression of dpp-lacZ (H). negative effect of these constructs on endogenous Ci. Amongst these, Ci 75 had strongest dominant negative effect, while Ci Cell had minimal dominant negative effect ( Fig. 7D; Suppl. Fig. 7 ; Suppl. Fig. 8 ; Suppl. Table 3 ). We examined if over-expression of dA2BP1 could rescue these phenotypes. Co-expression of dA2BP1 with Ci ΔC3 , Ci 75 or Ci Cell resulted in the restoration of kn expression in AB cells (Suppl. Fig. 7E ; Suppl. Fig. 7, Suppl. Fig. 8 ; Suppl. Table 3 ). It is likely that dA2BP1 binds to these dominant negative forms of Ci and sequester them from kn promoter, thereby allowing endogenous Ci to activate kn. However, dA2BP1 had less significant effect on the dominant negative activity of two constructs, Ci NZn and Ci NZnΔNLS ; the latter has a partial deletion of Zn finger domain in addition to the entire C-terminal dCBP-binding domain ( Fig. 7F-G; Suppl. Fig. 7, Suppl. Fig. 8 ; Suppl. Table 3 ). It is possible that these constructs, while retaining some ability to bind regulatory sequences of kn, have lost the domains essential for interaction with dA2BP1. Based on above-described observations with different forms of Ci, we conclude that residues 441-609aa of Ci are required for binding to the regulatory sequences of kn and residues 616-649 are required for interacting with dA2BP1.
Supporting this, ChIP experiments for dA2BP1, done using chromatin isolated from wing discs expressing Ci 75 , did not affect dA2BP binding to kn + (Fig. 6D ). However, when Ci NZΔNLS was expressed, binding of dA2BP1 to kn + was abolished (Fig. 6E) .
This was further confirmed by immunoprecipitation experiments where Ci GA2 and Ci NZnΔNLS were tested for their ability to bind to dA2BP1. While we were able to co-precipitate Ci GA2 with dA2BP1 ( Fig 8A) , we were unable to pull down Ci NZnΔNLS through precipitation of dA2BP1 ( Fig. 8C ), suggesting that residues 616-649 are indeed required for binding to dA2BP1.
Taken together, these results show that while dA2BP1 can bind to "naked" DNA in-vitro, its interaction with Ci is important for it to bind to kn promoter and thereby regulate kn expression in the wing disc.
Discussion
Hedgehog (Hh) is an important signaling molecule regulating a variety of events throughout development as well as adult life of all higher eukaryotes. All functions of Hh are mediated by Ci (Methot and Basler, 2001) . This raises the question of how spatio-temporal diversity in the output of Hh pathway is established. It is generally assumed that tissue-specific factors act to regulate Ci function. So far, the only report of such factors is of Teashirt (Tsh) and Armadillo (Arm). It is believed that these two proteins complex with Ci to specify naked cuticle at distinct positions along the antero-posterior axis of Drosophila embryos (Angelats et al., 2002) . However, it is still unclear how they might influence Ci function.
In this report, we demonstrate a role for dA2BP1 as a co-factor of Ci necessary for regulating kn expression during wing development. We identified dA2BP1, an ortholog of Ataxin2 Binding Protein or Fox-1, in a previous study involving identification of genes with differential expression in wing and haltere discs (Bajpai et al., 2004) . We show that loss of dA2BP1 leads to loss of intervein region between L3-L4 veins of (-) or after incubation with wing disc lysate (+). The immunoprecipitated products were subjected to Western blot analyses using anti-Ci antibodies. Co-precipitation of Ci was observed only with C-terminal domain, suggesting that this domain is essential for binding to Ci. adult wings-a phenotype similar to kn mutants. Furthermore, down regulation of dA2BP1 leads to a complete loss of kn RNA expression.
The role of Hh in patterning the vein and intervein regions is well established (reviewed in de Celis, 2003) . kn has been shown to be a direct target of Hh signaling in patterning the intervein region between veins 3 and 4. Results from our experiments show that while overexpression of Ci leads to upregulation of kn, down-regulation of dA2BP1 can suppress this effect, suggesting that dA2BP1 is necessary for Cimediated kn expression. Immunoprecipitation experiments suggest interactions at the protein levels (which could be either direct or indirect) between dA2BP1 and the 155 kDa activator form of Ci. In-vitro, Ci (Hersh and Carroll, 2005) and dA2BP1 (this study) can independently bind to upstream sequence of kn; ChIP experiments done using truncated versions of Ci suggest that in-vivo binding of dA2BP1 on kn enhancer is dependent on Ci but not vice-versa. Thus, dA2BP1 appears to be a factor recruited by Ci to bring about transcription of kn. This appears to be context (or promoter-) dependent since, in the same cells that express kn, Ci is also known to regulate the expression of dpp and, this function is independent of dA2BP1.
In vivo genetic interaction studies followed by immunoprecipitation experiments with different forms of Ci suggest interactions between dA2BP1 and repressor forms of Ci too. However, it is likely that interaction between dA2BP1 and full-length activator form of Ci is important during wing morphogenesis.
The promoter-specific role of dA2BP1 leads to questions on the nature of interactions between dA2BP1 and Ci to activate kn, but not for the activation of dpp. It is possible that dA2BP1 may enhance the stability of binding and transcriptional activator function of Ci on kn promoter. In this context, it is to be noted that dA2BP1 binds to the Zinc finger domain of Ci, which is the main DNA binding domain. As dA2BP1 has DNA-binding properties (based on in vitro evidence), we suggest that once bound to Ci, dA2BP1 may anchor on DNA and this helps stabilizing binding of Ci to kn promoter. As binding of dA2BP1 on kn-promoter is also sequence dependent (based on the results of in vitro electromobility shift experiments: dA2BP1 binds sequences from kn promoter and not those of dpp), this property may also help in better stabilizing Ci-dA2BP1 complex on kn promoter, which does not have classical Ci/Gli-binding sites. Alternatively, when both Ci and dA2BP1 together bind to kn sequences, dA2BP1 may recruit additional factors on to the chromatin. This local chromatin modulation may help in regulating kn expression ( Fig. 9A, B) . Identification of other proteins, if any, that are part of dA2BP1-Ci complex may help us in understanding precise molecular mechanism by which dA2BP1 modulates Ci function. dA2BP1 appears to be a complex protein with a predicted RNAbinding motif and poly-glutamine domains. RNAi-mediated knockdown of dA2BP1 using ubiquitous GAL4 drivers such as tubulin-GAL4, hs-GAL4 etc were early larval lethal, suggesting that dA2BP1 has vital Fig. 5 . dA2BP1 has DNA-binding ability. Electromobility shift assays carried out to examine DNA-binding ability of dA2BP1. (A) Different amounts of purified dA2BP1 was incubated with radio-labelled kn or dpp probes (144 bp and 191 bp long fragments as described in Suppl. Table 1) , both with known Ci-binding motifs. Note, mobility shift is observed only for kn probe. (B) The binding of dA2BP1 to radio-labeled kn probe could be competed out using increased amount of unlabelled kn probe. + 1:50, ++ 1:100 and +++ 1:200 dilutions of labeled to cold probes. (C) dA2BP1 causes shift in the mobility of radio-labeled oligo-probes of kn, both with intact (Probe A) and mutated Ci-binding sites (Probe B). The binding of dA2BP1 to Probe A can be competed with cold Probe B suggesting that dABP1 may bind to regions outside the Ci-binding regions. See Suppl. Text for details of the probes used here. function during development. Its dynamic expression pattern too indicates the same. Here we have analyzed just one part of its function. It is likely that it interacts with different proteins/RNA in different tissues generating diversity in its functions. (G-G') Co-expression of dA2BP1 fails to restore kn-lacZ expression in Ci NZn expressing wing discs. This suggests that the non-overlapping region between Ci 75 and Ci NZn is required for binding to dA2BP1. Fig. 8 . Amino acids 616-649 in Ci are required for its interaction with dA2BP1. dA2BP1 was immunoprecipitated from wildtype wing discs (A), wing discs over-expressing Ci GA2 (B) or Ci NZn NLS (C) followed by Western blot analysis using anti-Ci antibodies. For wing discs over-expressing Ci NZn NLS immunoprecipitation was also done using anti-HA antibodies (D, Ci NZn NLS is HA-tagged) followed by Western blot analysis using anti-dA2BP1 antibodies. 
